🔎 Trials Near Me

Home › Scleroderma › Michigan › Ann Arbor

Scleroderma clinical trials in Ann Arbor, MI

9 studies for Scleroderma are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study of AZD0120 in Autoimmune Diseases

RecruitingPhase 1/2
  • Research Site, Ann Arbor
Ages 18 to 75 · All sexes · Updated Nov 10, 2026 · NCT07295847

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

RecruitingPhase 1/2
  • Nkarta Investigational Site, Ann Arbor
Ages 18 to 75 · All sexes · Updated Oct 30, 2026 · NCT06733935

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

RecruitingPhase 2/3
  • University of Michigan, Ann Arbor
Ages 18 to 75 · All sexes · Updated Oct 16, 2026 · NCT06328777

A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis

RecruitingPhase 3
  • University of Michigan, Ann Arbor
Ages 18 and older · All sexes · Updated Oct 14, 2026 · NCT07497087

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

RecruitingPhase 2/3
  • GSK Investigational Site, Ann Arbor
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05878717

Platform Clinical Study for Conquering Scleroderma

RecruitingPhase 2
  • University of Michigan, Ann Arbor
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072

Systemic Sclerosis DIet for GastrointESTinal Symptoms

Recruiting
  • University of Michigan, Ann Arbor
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT07402226

A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis

RecruitingPhase 2
  • Galderma Investigational Site # 8743, Ann Arbor
Ages 18 and older · All sexes · Updated Mar 31, 2026 · NCT07047690

The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life

Recruiting
  • University of Michigan, Ann Arbor
Ages 18 and older · All sexes · Updated Jan 8, 2026 · NCT06675344

About Scleroderma

Scleroderma is an autoimmune disease that causes inflammation and thickening in the skin and other areas of the body. The exact cause of scleroderma is unknown.

More about Scleroderma on MedlinePlus

Scleroderma trials in other cities

Other studies in Ann Arbor

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.